353
Participants
Start Date
April 30, 2012
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
AZD5423
oral inhaled
Budesonide
oral inhaled
Placebo
oral inhaled
Research Site, Doganovo
Research Site, Plovdiv
Research Site, Sofia
Research Site, Varna
Research Site, Brest
Research Site, Marseille
Research Site, Montpellier
Research Site, Nice
Research Site, Pessac
Research Site, Balassagyarmat
Research Site, Budapest
Research Site, Deszk
Research Site, Százhalombatta
Research Site, Foggia
Research Site, Padua
Research Site, Verona
Research Site, Napoli
Research Site, Pisa
Research Site, Bialystok
Research Site, Gorzow Wlkp
Research Site, Lodz
Research Site, Proszowice
Research Site, Tarnów
Research Site, Barnaul
Research Site, Chelyabinsk
Research Site, Moscow
Research Site, Novosibirsk
Research Site, Saint Petersburg
Research Site, Vladikavkaz
Research Site, Yaroslavl
Research Site, Yekaterinburg
Research Site, Vráble
Research Site, Bratislava
Research Site, Humenné
Research Site, Košice
Research Site, Spišská Nová Ves
Research Site, Zvolen
Research Site, Donetsk
Research Site, Ivano-Frankivsk
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Odesa
Research Site, Poltava
Research Site, Zaporizhzhya
Lead Sponsor
AstraZeneca
INDUSTRY